Tag: #Global Trends

Key Development Revolution Medicines has secured a positive recommendation from the European Medicines Agency's Committee for Medicinal Products for Human... Read more

Key Development The U.S. Food and Drug Administration has established a new Exclusivity Board within its Center for Drug Evaluation... Read more

Key Development City Therapeutics has raised approximately US200millioninanupsizedinitialpublicoffering,pricing11.1millionsharesatUS18 each and listing on Nasdaq under the ticker CTY. Beyond the fundraising,... Read more

Key Development AstraZeneca has entered an AI-enabled drug discovery collaboration with insitro worth up to approximately US$1.5 billion, targeting metabolic... Read more

Key Development Gilead Sciences has entered a collaboration with Vir Biotechnology worth up to approximately US$1.88 billion to develop three... Read more

Key Development Sanofi has avoided a potentially substantial EU antitrust fine after the European Commission accepted legally binding commitments addressing... Read more

Key Development Johnson & Johnson's oral IL-23 receptor inhibitor Icotyde (icotrokinra) has surpassed 20,000 patient starts through nearly 9,000 prescribers... Read more

Key Development Lonza has upgraded its medium-term financial ambitions, targeting 10–13% average organic sales growth at constant exchange rates and... Read more

Key Development Zealand Pharma has entered a collaboration with Generate Biomedicines worth up to nearly US$1.2 billion in milestone payments,... Read more